European Journal of Organic Chemistry · 2013 · 16 citations · 23 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryPeptide ChemistryPeptide Drug DiscoverySolid-phase SynthesisFmoc ChemistryPeptide Medicinal ChemistrySolid-phase Organic SynthesisSolid-phase Peptide SynthesisTherapeutic Peptides
Abstract A milder and more efficient procedure for the synthesis of sulfonamides by activating sulfonic acid groups as the corresponding sulfonate esters of ethyl 2‐cyano‐2‐(hydroxyimino)acetate (Oxyma) is reported. This method is greener than all other existing protocols for the purpose. Other important advantages lie in (a) its applicability to less nucleophilic anilines under ambient and milder conditions and (b) its compatibility with solid phase peptide synthesis and acid‐labile groups such as trityl (Trt) and t Bu, which empowers the solid phase synthesis of sulfonamides of various peptides. To illustrate this, the syntheses of three sulfonamide derivatives of the peptide GAILG‐NH 2 , which is relevant in the context of drug design against type 2 diabetes, are demonstrated by using Fmoc‐based solid‐phase peptide synthesis (SPPS).
23
Comprehensive organic chemistry
D. H. R. BARTON, W. David Ollis · Tetrahedron Letters · 1978 · 2.8K citations
Comprehensive medicinal chemistry
H. Timmerman, Aalt Bast, H. van der Goot et al. · Trends in Pharmacological Sciences · 1991 · 1.2K citations
Comprehensive Medicinal Chemistry
Quantitative Structure-Activity Relationships · 1991 · 749 citations
Comprehensive organic chemistry
Journal of Quantitative Spectroscopy and Radiative Transfer · 1979 · 539 citations